S100A11 and Insulin resistance: Furthermore, S100A11 was nonlinearly correlated with FPG, FPI, HOMA-IR, hepatic ISI, WBISI, and CIR in patients with IGT and DM, suggesting that S100A11 is involved in insulin resistance, pancreatic β-cell function, and hepatic and whole-body insulin sensitivity.